Portable CT developer NeuroLogica said it has acquired all xenon CT perfusion (XeCT) technology assets from Diversified Diagnostic Products of Houston.
XeCT measures cerebral blood flow, and the technology enhances NeuroLogica's portable CT capabilities in the ER, ICU, and OR, according to the Danvers, MA-based firm. Terms of the deal were not disclosed.
Related Reading
NeuroLogica notches 50th hospital sale, November 28, 2007
NeuroLogica wins Ceretom install, November 9, 2007
Road to RSNA, CT, NeuroLogica, October 22, 2007
NeuroLogica adds cranial stabilization unit, September 18, 2007
NeuroLogica scores another NFL contract, August 29, 2007
Copyright © 2008 AuntMinnie.com
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
